# Investigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 Diabetes

> **NCT04851223** · — · UNKNOWN · sponsor: **University of Roehampton** · enrollment: 130 (estimated)

## Conditions studied

- Type2 Diabetes Mellitus
- Pre Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04851223
- **Lead sponsor:** University of Roehampton
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-22
- **Primary completion:** 2023-06-22
- **Final completion:** 2023-09-22
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2022-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04851223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04851223, "Investigating Plasma Biomarker Molecules Associated With the Progression of Prediabetes to Overt Type 2 Diabetes". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04851223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*